Table 2.
Bacteria isolated in conjunctival sac and Meibomian gland among MGD patients and controls
| Isolated bacteria | n (%)
|
P-value | |
|---|---|---|---|
| CS | MG | ||
| None | 113 (80.7%) | 64 (45.7%) | <0.001* |
| Staphylococcus (G+) | 19 (13.6%) | 67 (47.9%) | <0.001* |
| S. epidermidis | 15 (10.7%) | 65 (46.4%) | <0.001* |
| S. aureus | 2 (1.4%) | 4 (2.9%) | 0.409 |
| S. hominis | 2 (1.4%) | 1 (0.7%) | 0.562 |
| S. capitis | 1 (0.7%) | 2 (1.4%) | 0.562 |
| S. warneri | 0 (0%) | 1 (0.7%) | 0.316 |
| Corynebacterium (G+) | 4 (2.9%) | 6 (4.3%) | 0.520 |
| C. macginleyi | 4 (2.9%) | 5 (3.6%) | 0.735 |
| C. pseudodiphtheriticum | 0 (0%) | 1 (0.7%) | 0.316 |
| Microbacteriaceae (G+) | 4 (2.9%) | 14 (10.0%) | 0.015* |
| Microbacterium | 1 (0.7%) | 3 (2.1%) | 0.314 |
| Micrococcaceae | 3 (2.1%) | 7 (5.0%) | 0.198 |
| Micrococcus luteus | 0 (0%) | 4 (2.9%) | 0.044* |
| Moraxella osloensis (G−) | 3 (2.1%) | 0 (0%) | 0.082 |
| Bacillus (G+) | 0 (0%) | 4 (2.9%) | 0.044* |
| B. cereus | 0 (0%) | 2 (1.4%) | 0.156 |
| B. circulans | 0 (0%) | 1 (0.7%) | 0.316 |
| B. thermoamylovorans | 0 (0%) | 1 (0.7%) | 0.316 |
| Paenibacillus (G+) | 0 (0%) | 1 (0.7%) | 0.316 |
| Lysinibacillus (G+) | 0 (0%) | 1 (0.7%) | 0.316 |
| Xanthomonadaceae (G−) | 0 (0%) | 1 (0.7%) | 0.316 |
Notes:
*
P<0.05. G+ and G– represent the Gram positive and negative bacteria, respectively.
Abbreviations: CS, conjunctival sac; MG, Meibomian gland; MGD, Meibomian gland dysfunction; n (%): number of patients (percentage in CS or MG).